Phibro Animal Health Corporatio - stock earnings
PAHC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 1.3 million USD | 249.9 million USD |
| 2023Q3 | -8.0 million USD | 231.3 million USD |
| 2023Q2 | 11.5 million USD | 255.0 million USD |
| 2023Q1 | 10.0 million USD | 245.7 million USD |
| 2022Q4 | 7.2 million USD | 244.6 million USD |
| 2022Q3 | 3.9 million USD | 232.5 million USD |
| 2022Q2 | 7.5 million USD | 255.3 million USD |
| 2022Q1 | 17.7 million USD | 239.6 million USD |
| 2021Q4 | 17.5 million USD | 232.7 million USD |
| 2021Q3 | 6.5 million USD | 214.7 million USD |
| 2021Q2 | 17.1 million USD | 220.3 million USD |
| 2021Q1 | 12.2 million USD | 211.7 million USD |
| 2020Q4 | 12.8 million USD | 206.1 million USD |
| 2020Q3 | 12.3 million USD | 195.2 million USD |
| 2020Q2 | 5.6 million USD | 185.9 million USD |
| 2020Q1 | 13.5 million USD | 210.7 million USD |
| 2019Q4 | 11.9 million USD | 214.0 million USD |
| 2019Q3 | 2.5 million USD | 189.7 million USD |
| 2019Q2 | 8.8 million USD | 203.9 million USD |
| 2019Q1 | 14.8 million USD | 205.7 million USD |
| 2018Q4 | 14.7 million USD | 218.2 million USD |
| 2018Q3 | 16.3 million USD | 200.2 million USD |
| 2018Q2 | 22.1 million USD | 211.8 million USD |
| 2018Q1 | 19.8 million USD | 208.9 million USD |
| 2017Q4 | 7.0 million USD | 205.9 million USD |
| 2017Q3 | 15.9 million USD | 193.4 million USD |
| 2017Q2 | 15.4 million USD | 194.8 million USD |
| 2017Q1 | 23.6 million USD | 189.9 million USD |
| 2016Q4 | 13.4 million USD | 191.6 million USD |
| 2016Q3 | 12.2 million USD | 188.0 million USD |
| 2016Q2 | 15.2 million USD | 189.2 million USD |
| 2016Q1 | 18.6 million USD | 183.5 million USD |
| 2015Q4 | 30.2 million USD | 191.8 million USD |
| 2015Q3 | 18.8 million USD | 187.1 million USD |
| 2015Q2 | 5.0 million USD | 185.0 million USD |
| 2015Q1 | 19.4 million USD | 187.5 million USD |
| 2014Q4 | 15.4 million USD | 188.7 million USD |
| 2014Q3 | 20.5 million USD | 187.5 million USD |
| 2014Q2 | -17.6 million USD | 183.7 million USD |
| 2014Q1 | 6.4 million USD | 173.3 million USD |
| 2013Q4 | 2.3 million USD | 172.7 million USD |
| 2013Q3 | 5.8 million USD | 162.2 million USD |
| 2013Q2 | 6.0 million USD | 164.2 million USD |
| 2013Q1 | 4.2 million USD | 162.7 million USD |
| 2012Q4 | 12.1 million USD | 164.2 million USD |
| 2012Q3 | 2.7 million USD | 162.1 million USD |
| 2012Q2 | 7.0 million USD | 654.1 million USD |
| 2011Q2 | 9.0 million USD | 136.3 million USD |
| 2010Q2 | -18.0 million USD | 148.4 million USD |
| 2009Q4 | 32.5 million USD | 151.8 million USD |
| 2009Q3 | 9.0 million USD | 136.3 million USD |
| 2009Q2 | 13.8 million USD | 139.1 million USD |
| 2009Q1 | -4.4 million USD | 129.0 million USD |
| 2008Q4 | -8.9 million USD | 127.7 million USD |
| 2008Q3 | -8.7 million USD | 136.2 million USD |
| 2008Q2 | 6.3 million USD | 143.3 million USD |
| 2008Q1 | -12.3 million USD | 132.4 million USD |
| 2007Q4 | 5.6 million USD | 123.2 million USD |
| 2007Q3 | 2.5 million USD | 112.6 million USD |
| 2007Q2 | 6.9 million USD | 122.8 million USD |
| 2007Q1 | 500000 USD | 108.4 million USD |
| 2006Q4 | 2.2 million USD | 117.0 million USD |
| 2006Q3 | -16.3 million USD | 104.8 million USD |
| 2006Q2 | -7.0 million USD | 105.2 million USD |
| 2006Q1 | -1.4 million USD | 100.9 million USD |
| 2005Q4 | -2.0 million USD | 99.7 million USD |
| 2005Q3 | -2.8 million USD | 92.6 million USD |
| 2005Q2 | -6.4 million USD | 95.2 million USD |
| 2005Q1 | -5.6 million USD | 90.3 million USD |
| 2004Q4 | -7.6 million USD | 92.0 million USD |
| 2004Q3 | -100000 USD | 86.9 million USD |
| 2004Q2 | -9.3 million USD | 92.8 million USD |
| 2004Q1 | -400000 USD | 86.0 million USD |
| 2003Q4 | 21.3 million USD | 90.7 million USD |
| 2003Q3 | 1.3 million USD | 85.0 million USD |
| 2003Q2 | -7.3 million USD | 71.2 million USD |
| 2003Q1 | -2.3 million USD | 90.2 million USD |
| 2002Q4 | -7.8 million USD | 90.1 million USD |
| 2002Q3 | -200000 USD | 86.3 million USD |
| 2002Q2 | ? USD | 74.9 million USD |
| 2002Q1 | ? USD | 88.2 million USD |
| 2001Q4 | ? USD | 82.8 million USD |
| 2001Q3 | ? USD | 94.7 million USD |
| 2001Q2 | ? USD | 104.5 million USD |
| 2001Q1 | ? USD | 103.8 million USD |
| 2000Q4 | ? USD | 83.3 million USD |
| 2000Q3 | ? USD | 72.8 million USD |
| 2000Q2 | 3.3 million USD | 96.4 million USD |
| 2000Q1 | 9.5 million USD | 79.4 million USD |
PAHC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 32.6 million USD | 977.9 million USD |
| 2022 | 49.2 million USD | 942.3 million USD |
| 2021 | 54.4 million USD | 833.4 million USD |
| 2020 | 33.6 million USD | 800.4 million USD |
| 2019 | 54.7 million USD | 828.0 million USD |
| 2018 | 64.9 million USD | 820.0 million USD |
| 2017 | 64.6 million USD | 764.3 million USD |
| 2016 | 82.7 million USD | 751.5 million USD |
| 2015 | 60.3 million USD | 748.6 million USD |
| 2014 | -3.1 million USD | 691.9 million USD |
| 2013 | 24.9 million USD | 653.2 million USD |
| 2012 | 7.0 million USD | 654.1 million USD |
| 2011 | -12.9 million USD | 618.3 million USD |
| 2010 | 42.1 million USD | 594.2 million USD |
| 2009 | -8.3 million USD | 537.1 million USD |
| 2008 | 2.2 million USD | 511.4 million USD |
| 2007 | -6.7 million USD | 453.0 million USD |
| 2006 | -13.1 million USD | 398.4 million USD |
| 2005 | -22.1 million USD | 364.4 million USD |
| 2004 | 12.9 million USD | 354.4 million USD |
| 2003 | -17.6 million USD | 337.8 million USD |
| 2002 | -51.8 million USD | 328.7 million USD |
| 2001 | -14.9 million USD | 319.7 million USD |
| 2000 | 10.1 million USD | 323.0 million USD |
PAHC
Price: $12.73
52 week price:
Dividend Yield: 0.04%
5-year range yield:
Forward Dividend Yield: 3.77%
Payout Ratio: 129.73%
Payout Ratio Range:
Dividend Per Share: 0.48 USD
Earnings Per Share: 0.37 USD
P/E Ratio: 32.54
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 51500
Ebitda: 30.9 millionMarket Capitalization: 523.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 11
DGR5: 3.82%